01 7Lutathera
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 445
2019 Revenue in Millions : 441
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 475
2020 Revenue in Millions : 445
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 471
2021 Revenue in Millions : 475
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 605
2022 Revenue in Millions : 471
Growth (%) : 28
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 724
2023 Revenue in Millions : 605
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 167
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 441
2018 Revenue in Millions : 167
Growth (%) : 164
